Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Cellular Retinaldehyde-Binding Protein-Like (Cralbpl), A Novel Human Sec14p-Like Gene That Is Upregulated In Human Hepatocellular Carcinomas, May Be Used As A Marker For Human Hepatocellular Carcinomas

Cloning and Characterization of A Novel, Human Cellular Retinaldehyde-Binding Protein Cralbp-Like (cralbpl) Gene

Genes Encoding Pir51, Beclin 1, RbAp48 and Aldolase B Are Up or Down-Regulated in Human Primary Hepatocellular Carcinoma.

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Expression and functional analysis of the cellular retinoic acid binding protein from silkworm pupae (Bombyx mori).

Human CRYL1, a Novel Enzyme-Crystallin Overexpressed in Liver and Kidney and Downregulated in 58% of Liver Cancer Tissues from 60 Chinese Patients, and Four New Homologs from Other Mammalians.

HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein.

Molecular cloning and characterization of LAPTM4B , a novel gene upregulated in hepatocellular carcinoma

Expression Of Alphab-Crystallin Gene In Hepatocellular Carcinoma And Its Prognostic Significance

A Novel Cdna Encodes a Putative Hraly-Like Protein, Hralyl

Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma

Identification and characterization of a novel human hepatocellular carcinoma-associated gene

Characterization of a Human Sec14-like Protein Cdna SEC14L3 Highly Homologous to Human SPF/TAP.

RRS1: an prognostic and diagnostic biomarker of hepatocellular carcinoma from a comprehesive analysis

[Cloning, prokaryotic expression and polyclonal antibody preparation of HCCR: a new biomarker for hepatocellular carcinoma].

Expression and Prognostic Significance of the Alpha B-Crystallin Gene in Human Hepatocellular Carcinoma

Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930.

Expression of signal recognition particle 14 in hepatocellular carcinoma and its relationship with disease progression and patient survival

Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinoma

KIAA0101 (OEACT-1), an Expressionally Down-Regulated and Growth-Inhibitory Gene in Human Hepatocellular Carcinoma

Cloning and Functional Characterization of A Novel Long Non-Coding Rna Gene Associated with Hepatocellular Carcinoma